Miltenyi Biotec CliniMACS stem cell selection device
Showing 1 - 25 of >10,000
Hematologic Malignancies Trial in Milwaukee (CliniMACs)
Active, not recruiting
- Hematologic Malignancies
- CliniMACs
-
Milwaukee, WisconsinChildren's Hospital of Wisconsin
Apr 4, 2022
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Miltenyi CliniMACS Prodigy ® system
- (no location specified)
Mar 23, 2023
Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using
Recruiting
- Relapsed Pediatric ALL
- +2 more
- In Vitro T cells depletion using CliniMCAS system
-
Shanghai, ChinaShanghai Children's Medical Center
Sep 28, 2022
Graft Vs Host Disease, Graft-versus-host-disease Trial in San Francisco (CliniMacs®)
Recruiting
- Graft Vs Host Disease
- Graft-versus-host-disease
- CliniMacs®
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 2, 2022
Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee
Completed
- Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
- Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
- CliniMACS (CD+3, CD+19 depletion)
- +2 more
-
Milwaukee, WisconsinChildren's Hospital of Wisconsin
Oct 21, 2021
Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))
Not yet recruiting
- Leukemia
- +12 more
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- (no location specified)
Mar 20, 2023
Sickle Cell Disease Trial in Chicago (aß+ T-cell depletion with Miltenyi CliniMACS system)
Recruiting
- Sickle Cell Disease
- αβ+ T-cell depletion with Miltenyi CliniMACS system
-
Chicago, IllinoisThe University of Chicago
May 13, 2022
Allogeneic Hematopoietic Cell Transplantation Trial in Cincinnati (TCRaß+/CD19+ depleted allogeneic hematopoietic stem cell
Recruiting
- Allogeneic Hematopoietic Cell Transplantation
- TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplant (HSCT)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Sep 21, 2021
Immunodeficiencies Trial in Philadelphia (CliniMACs)
Active, not recruiting
- Immunodeficiencies
- CliniMACs
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 1, 2022
Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent
Available
- Hematologic Malignancies
- +2 more
- CliniMACS CD34 Reagent System
-
Durham, North CarolinaDuke University Medical Center
Nov 12, 2021
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS
Recruiting
- Immunodeficiencies
- Immune Dysregulation Syndromes
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 8, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell
No longer available
- Acute Lymphoblastic Leukemia
- +11 more
- CD34+ enriched, T Cell Depleted donor stem cell product
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 25, 2021
Systemic Lupus Erythematosus, Systemic Sclerosis Trial in Philadelphia (Depletion of CD3/CD19 in an autologous stem cell
Recruiting
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- Depletion of CD3/CD19 in an autologous stem cell transplant
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
May 23, 2022
Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)
Recruiting
- Hematologic Diseases
- Allogeneic Stem Cell Transplant
- CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022
Hematologic Malignancies Trial in Chicago, New York (device, drug, radiation)
Recruiting
- Hematologic Malignancies
- CliniMACS® CD34 Reagent System
- +7 more
-
Chicago, Illinois
- +1 more
Sep 20, 2022
Leukemia, Bone Marrow Failure Syndrome, Immunodeficiencies Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using
Available
- Leukemia
- +2 more
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 2, 2021
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
Leukemia, Myelocytic, Acute Trial in United States (CD34+ selection with CliniMACS device)
Completed
- Leukemia, Myelocytic, Acute
- CD34+ selection with CliniMACS device
-
Duarte, California
- +7 more
Oct 21, 2021
Malignant Non-Hodgkin Lymphomas Trial in Berne (CD34+ cell selection)
Active, not recruiting
- Malignant Non-Hodgkin Lymphomas
- CD34+ cell selection
-
Berne, SwitzerlandDepartment for Medical Oncology; University Hospital/Inselspital
Jul 29, 2021
Pediatric Patients, Hematologic Malignancy, Other Hematologic Condition Trial in Aurora (CliniMACS Plus Instrument)
Not yet recruiting
- Pediatric Patients
- +2 more
- CliniMACS Plus Instrument
-
Aurora, ColoradoChildren's Hospital Colorado
Jun 29, 2022
Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS
Recruiting
- Chronic Myeloid Leukemia (CML)
- +5 more
- CliniMACS CD34+ Reagent System
- +8 more
-
New York, New YorkColumbia University Medical Center
Jun 17, 2020
Metachromatic Leukodystrophy Trial in Durham (Enriched Hematopoetic Stem Cell Infusion)
No longer available
- Metachromatic Leukodystrophy
- Enriched Hematopoetic Stem Cell Infusion
-
Durham, North CarolinaDuke University
Jul 15, 2022
AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)
Not yet recruiting
- AML
- +5 more
- Infusion of CD34 selected hematopoietic stem cells
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Sep 14, 2023